AMANDA DOUGLAS: Open Payments
NPI 1386122869 · MARYSVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 34 payments from 9 companies in 2025. Trend: 2023 $528 · 2024 $394 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $189 |
| ABBVIE INC. | 11 | $165 |
| Stryker Corporation | 1 | $85 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Alkermes, Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $39 |
| Insulet Corporation | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, NEPTUNE, Auvelity, LYBALVI, Cologuard Collection Kit, HETLIOZ, FANAPT.
Industry payments across CA — which companies pay providers there.
